Press Release: GHIF Leads $7.5 Million Investment in Korean Vaccine Manufacturer
Global Health Investment Fund Leads 7.5 Million USD Investment into EuBiologics to Catalyze Availability of Low-Cost Oral Cholera Vaccine for the World’s Poor Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers August 27, 2014 (SEOUL): Global Health [...]